Scientific Advisory Board
Carmela R. Abraham, PhD
Boston University School of Medicine, Boston, Massachusetts
Professor of Biochemistry, Pharmacology and Experimental Therapeutics at Boston University School of Medicine, Boston, Massachusetts
Founder and Scientific Advisor, Klogene Therapeutics, Boston, Massachusetts
- Senior Editor “American Journal of Neurodegenerative Disease”
- Associate Editor “Journal of Alzheimer’s Disease”
Kaj Blennow, MD, PhD
Sahlgrenska University Hospital, Gothenburg, Sweden
Professor of Clinical Neurochemistry, University of Gothenburg, Sweden
Head of Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Gothenburg, Sweden
- Former researcher at the Medical Research Council (MRC), Sweden
Keith Crutcher, PhD
University of Cincinnati, Cincinnati, Ohio
Volunteer Professor, Department of Neurosurgery, University of Cincinnati, Cincinnati, Ohio
- Past Professor and Director of Research, Department of Neurosurgery, University of Cincinnati
- Former Scientific Review Officer, Emerging Technologies & Training in Neuroscience, Center for Scientific Review, NIH
Murali Doraiswamy, MBBS, FRCP
Duke University School of Medicine, Durham, North Carolina
Professor of Psychiatry and Medicine (Geriatrics), Duke University School of Medicine, Durham, North Carolina
Director of the Neurocognitive Disorders, Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, North Carolina
- Member, Duke Institute for Brain Sciences
- Member, Duke Center for Applied Genomics and Precision Medicine
- Co-author, “The Alzheimer’s Action Plan”